This guide explains how it works, what it usually costs, how vial dosing is handled, and what changed legally in 2026
Protect access to compounded medications make your voice heard
Semaglutide is not recommended for use in patients with type 1 diabetes or diabetic ketoacidosis
Tirzepatide May Be a Better Fit If: Maximum weight loss is your primary goal, and tirzepatide consistently produces greater reductions in clinical data You have type 2 diabetes and want superior blood sugar control (SURPASS-2 showed clear superiority over semaglutide) You've tried semaglutide and plateaued, and the dual-agonist mechanism may produce additional response You respond well to lower doses, and tirzepatide 5mg matches semaglutide 2.4mg for weight loss Semaglutide May Be a Better Fit If: Cardiovascular protection is important, as the SELECT trial provides strong evidence for heart benefit You prefer an oral option: oral semaglutide exists (the Ozempic pill for diabetes, which reformulated and renamed Rybelsus in 2026, and the Wegovy pill for weight)
The good news is that, unlike some other GLP-1 medications, Wegovy does not reduce the effectiveness of oral contraceptives